Antineoplastic Agents

Antineoplastic Agents Companies (22)

Antineoplastic Agents Products (97)

  • Product Goserelin Acetate PFS 3.6 mg

    Description: Sterile depot formulation of goserelin acetate supplied in a pre-filled syringe for subcutaneous implantation. It is a long-acting gonadotropin-releasing hormone (GnRH) agonist designed for sustained suppression of sex hormone production with extended-release dosing, typically administered on...
  • Product Neutromax 30 M I.U./ 48 M I.U.

    Filgrastim is a recombinant methionyl human granulocyte colony stimulating factor (r-Met-Hu-GCSF), produced by bacterial fermentation. Filgrastim is used to treat neutropenia, a side effect of chemotherapy, which makes patients more susceptible to bacterial infections.
    Biosidus Filgrastim product is av...
  • Product Oxaliplatin SEDICO vials

    Treat certain cancers, especially colorectal (colon and rectal) cancer.
  • Product Lomustine

    Product Name: Lomustine

    CAS:13010-47-4

    Molecular Formula: C9H16ClN3O2

    Molecular Weight: 233.7

    Properties: Yellow, crystalline powder

    ...
  • Product Bortezomib

    Carelife offers a wide range of products which includes Clindamycin Hydrochloride, Phosphate, Palmitate Hydrochloride. 

     We also offer:  

    Iron sucrose
    Ferric carboxymaltose
    Pemetrexed disodium
    Granisetron HCl
    Mitoxantrone HCl...
  • Product Flupentixol Dihydrochloride BP/EP

    Flupentixol Dihydrochloride is an antipsychotic medication belonging to the thioxanthene class. It is primarily used to treat schizophrenia and other mental health disorders, including depression.

    Mechanism of Action:

    Alters the balance of neurotransmitters in the brain, parti...
  • Product Icotinib Hydrochloride

    Packaging Specification: 5.0 kg per box
  • Product Amifostine for Injection

    Chemotherapy: used prior to chemotherapy in patients with various cancers, including lung cancer, ovarian cancer, breast cancer, nasopharyngeal carcinoma, bone tumors, gastrointestinal tumors, and hematological malignancies, to significantly ease the toxic effects of chemotherapeutic agents on the kidneys,...
  • Product ANTI CANCER INJECTABLES PEMETREXED

    Pemetrexed for Injection is a folate-dependent antineoplastic agent that disrupts folate-dependent metabolic processes essential for cell replication. It is used in the treatment of malignant pleural mesothelioma and non-small cell lung cancer.

    Pack Strengths Available: 100 mg, 500 mg
    qq...
  • Product Leuprorelin Acetate

    Treatment of endometriosis, uterine fibroids, prostate cancer, and central precocious puberty.

  • Product Enlength

    As a cornerstone drug for the treatment of multiple myeloma, Bortezomib is used throughout the induction, consolidation and maintenance therapies for myeloma. In 2020, Bortezomib was recommended as a first-line drug for the full management of multiple myeloma in the Guidelines for Diagnosis and Treatm...
  • Product Hydrobromic Acid in Acetic Acid

    It is mainly used in the industries of pharmaceuticals, pesticides, etc. In the field of medicine, it is used for synthesizing sedatives and anesthetics, and can also be applied in the petroleum industry, as well as in the production of synthetic dyes and fragrances.
  • Product Trabectedin

    Purity:99% 100g;1kg;10kg
  • Product 10-Deacetylbaccatin III

    Intermediate for Cabazitaxel,Docetaxel, Paclitaxel
  • Product Finished formulation for General products and Oncology products

    Finished formulation for General products and Oncology products 

    Formulations available in 
    -- Tablets 
    -- Capsules 
    -- Dry powder for suspension 


    Products packed in 
    -- Blister pack
    -- Drum pack 
    -- Bottle Pack
    -- Sachet 

  • Product Fludarabine Phospate

    Manufactured in OEB5 workshop which has passed FDA on-site audits for three times.US DMF and EU CEP are all available.
    Could support in registration APIs in all countries.
  • Product Enzalutamide Soft Capsules

    Suitable for metastatic resistance to prostate cancer (CRPC). After the failure of androgen deprivation of therapy (ADT), Enzalutamide can delay the progress of the disease by inhibiting the inhibitors of therogen receptor signaling pathway and improve the quality of life of patients.

Upcoming Events

  • CPHI & PMEC China 2026

    Shanghai New International Expo Center
    16 Jun 2026 - 18 Jun 2026
  • CPHI South East Asia 2026

    QSNCC, Bangkok, Thailand
    08 Jul 2026 - 10 Jul 2026
  • CPHI Korea 2026

    COEX, Seoul, Korea
    25 Aug 2026 - 27 Aug 2026

Pharmaceutical Industry Webinars